A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Shehab, Habibul Mohsin
Άλλοι συγγραφείς:	Yasmin, Hasina
Μορφή:	Thesis
Γλώσσα:	English
Έκδοση:	Brac University 2024
Θέματα:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Διαθέσιμο Online:	http://hdl.handle.net/10361/22683

Παρόμοια τεκμήρια

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
ανά: Tabassum, Nadira
Έκδοση: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
ανά: Mahee, Sadique Abdal
Έκδοση: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
ανά: Alim, Abdul
Έκδοση: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
ανά: Karmaker, Swastika
Έκδοση: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
ανά: Jahan, Nusrat
Έκδοση: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
ανά: Ishrat, Nowshin
Έκδοση: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
ανά: Bakar, Osama Bin Abu
Έκδοση: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
ανά: Chowdhury, Sariya Uzrat
Έκδοση: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
ανά: Islam, Md. Irfath
Έκδοση: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
ανά: Saha, Bithi Rani
Έκδοση: (2023)

Alzheimer's disease and marriage : an intimate account /
ανά: Wright, Lore K.
Έκδοση: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
ανά: Hassan, Md. Muhtaz
Έκδοση: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
ανά: Tasneem, Sadia
Έκδοση: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
ανά: Tamanna, Mst. Taskia
Έκδοση: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
ανά: Tasin, Md Abtahi
Έκδοση: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
ανά: Aziz, Farhin
Έκδοση: (2019)

An ambient assisted living system for Alzheimer’s patients
ανά: Abedin, Minhajul, κ.ά.
Έκδοση: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
ανά: Afra, Sumaiya
Έκδοση: (2022)

Marine compounds in the treatment of Alzheimer’s disease
ανά: Parveen, Sanjana
Έκδοση: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
ανά: Halim, Rabea
Έκδοση: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
ανά: Aana, Afsara Sumon
Έκδοση: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
ανά: Rahman, Quazi Ashikur, κ.ά.
Έκδοση: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
ανά: Mostofa, Golam
Έκδοση: (2022)

Gene editing for neurodegenerative diseases-A review
ανά: Sharna, Anika Islam
Έκδοση: (2023)

A review on adult neurogenesis in Alzheimer’s disease
ανά: Akter, Moriam
Έκδοση: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
ανά: Zaman, Rubaiyat
Έκδοση: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
ανά: Haque, Mushfiqul
Έκδοση: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
ανά: Roy, Aditya, κ.ά.
Έκδοση: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
ανά: Dey, Manashi
Έκδοση: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
ανά: Sani, Mehedi Hasan, κ.ά.
Έκδοση: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
ανά: Alam, Badrul, κ.ά.
Έκδοση: (2016)

Role of circular RNA in neurological disease
ανά: Salsabil, Labiba
Έκδοση: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
ανά: Mahbub, Riasat, κ.ά.
Έκδοση: (2022)

Skeleton /
ανά: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
ανά: Nusrat, Tanzina
Έκδοση: (2019)

হার্ট, ব্লাড, ফুড /
ανά: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
ανά: Rahman, Ahadina
Έκδοση: (2018)

Management of Diabetes patients during COVID-19
ανά: Pantho, G. M. Golam Mehebub
Έκδοση: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
ανά: Nour, Sabrina
Έκδοση: (2019)

Detection of alzheimer's disease using deep learning
ανά: Hasan, Mahmudul, κ.ά.
Έκδοση: (2021)